APA način citiranja (7. izdanje)

(16617218), D. O. K., (16617221), S. P., (16617224), Y. S., (16617227), M. J. S., (16617230), L. B., (11099556), J. O. B., & (16617233), J. L. (2025). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors.

Čikaški stil citiranja (17. izdanje)

(16617218), David Olayinka Kamson, Sushant Puri (16617221), Yingying Sang (16617224), Meihui Jessica Shi (16617227), Lindsay Blair (16617230), Jaishri O. Blakeley (11099556), i John Laterra (16617233). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.

MLA način citiranja (9. izdanje)

(16617218), David Olayinka Kamson, et al. Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.